+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Spiramycin"

Macrolide Antibiotics Market Report 2025 - Product Thumbnail Image

Macrolide Antibiotics Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Spiramycin is an antibiotic used to treat a variety of bacterial infections. It belongs to the macrolide class of antibiotics, which are used to treat infections caused by Gram-positive and Gram-negative bacteria. Spiramycin is used to treat infections of the respiratory tract, skin, and soft tissue, as well as certain sexually transmitted diseases. It is also used to prevent certain infections in immunocompromised patients. Spiramycin is available in both oral and injectable forms. It is generally well tolerated, with few side effects. However, it can cause gastrointestinal upset, rash, and other allergic reactions in some patients. The spiramycin market is highly competitive, with several major players offering a variety of formulations. These include generic and branded products, as well as combination products. The market is also characterized by a large number of generic manufacturers, which offer lower-priced alternatives to branded products. Companies in the spiramycin market include Pfizer, Merck, Sanofi, GlaxoSmithKline, Novartis, and AstraZeneca. Show Less Read more